LCAT and atherosclerosis: Findings from the IMPROVE study, which included 540 European individuals at high cardiovascular risk, showed no association between plasma LCAT concentrations and carotid intima-media thickness (IMT), a marker of preclinical atherosclerosis, in the overall population, even after adjusting for age, sex, HDL-C, and triglycerides.